BioSpace News Archive

Business

Neogen Announces Fourth-Quarter Earnings Release Date

Neogen Corporation (NASDAQ: NEOG) will issue its fourth-quarter earnings release before the opening of the market on Thursday, July 27, 2023.

July 11, 2023
·
1 min read
Business

Adicet Announces Appointment of Katie Peng to the Board of Directors

Adicet Bio, Inc. today announced the appointment of Katie Peng to its Board of Directors.

July 11, 2023
·
5 min read
Biotech Beach

Neurologics Unveils Life-Changing Evaluation Center in Newport Beach, Empowering Individuals to Amplify Their Brain Power

Neurologics, the global pioneer in advanced brain health care, proudly announces the grand opening of its transformative Assessment Center in the vibrant city of Newport Beach.

July 11, 2023
·
2 min read
Mallia Therapeutics Secures Seed Funding for its Novel Topical Treatment to Induce Hair Growth via Immune Modulation

Mallia Therapeutics GmbH, a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of hair loss, today announced that the newly founded company secured its seed financing.

July 11, 2023
·
6 min read
BioMidwest

Orsini Selected by BioMarin to Dispense ROCTAVIAN™, the First Gene Therapy for the Treatment of Severe Hemophilia A

Orsini Specialty Pharmacy, a leading independent specialty pharmacy focused on rare diseases and gene therapies, announced today that BioMarin Pharmaceutical has selected it to dispense ROCTAVIAN™ (valoctocogene roxaparvovec-rvox).

July 11, 2023
·
2 min read
Business

Evergreen Nephrology Names Craig Goguen Chief Executive Officer

Evergreen Nephrology is announcing the appointment of Craig Goguen as Chief Executive Officer, effective immediately.

July 11, 2023
·
2 min read
Lone Star Bio

Baylor Genetics Announces Epilepsy PanelLatest Panel Analyzes 397 Genes Associated with Several Epilepsy Conditions, Offering an Analysis of Well-studied, Actionable Genes Related to Many Syndromic and Non-Syndromic Epileptic Disorders

Baylor Genetics announced the availability of an Epilepsy Panel and a STAT Epilepsy Panel - with the latter intended for patients with new onset or change in seizure frequency or character.

July 11, 2023
·
3 min read
FDA

Urotronic Announces FDA Approval of Optilume® BPH Catheter System, Pioneering the Next Generation of Minimally Invasive Solutions for Enlarged Prostate Symptom Relief

Urotronic, Inc. today announced it has received U.S. Food and Drug Administration (FDA) approval of its Optilume® BPH Catheter System, a unique minimally invasive surgical therapy (MIST) that combines mechanical dilation using a proprietary double-lobe balloon with concurrent localized delivery of paclitaxel for the treatment of lower urinary tract symptoms (LUTS) secondary to BPH.

July 11, 2023
·
2 min read
Pharm Country

NeuroSolv Therapeutics LLC Advances Spinal Cord Injury Treatment with Development of Perineline™ and Support from AscellaHealth LLC, a Global Healthcare & Specialty Pharmacy Solutions Company

AscellaHealth LLC announces its commitment to provide NeuroSolv Therapeutics LLC with AscellaHealth’s comprehensive suite of services to support NeuroSolv’s clinical development and commercialization of Perineline™, a two-part, non-surgical therapy aimed at improving the treatment options available for patients with spinal cord injury.

July 11, 2023
·
5 min read
L7 Informatics Expands European Operations Strengthening Commitment to Pharmaceutical and Biotech Industries

L7 Informatics, Inc, the leading provider of scientific solutions for research, development, manufacturing, and quality control, is delighted to announce the expansion of its European operations

July 11, 2023
·
2 min read